Bioresorbable calcium phosphate paste ([alpha]-BSM) in treatment of calcaneal fractures .
This report has been verified
by one or more authors of the
original publication.
A Prospective Randomized Controlled Trial of a Bioresorbable Calcium Phosphate Paste ([alpha]-BSM) in Treatment of Displaced Intra-Articular Calcaneal Fractures
J Trauma. 2009 Oct;67(4):875-82.Exclusive Author Interview
Dr. Richard Buckley discusses the use of bioresorbable calcium phosphate paste ([alpha]-BSM) in treatment of calcaneal fractures.
47 patients with displaced intra-articular calcaneal fractures necessitating fixation (52 fractures), were randomized to receive either open reduction and internal fixation (ORIF) in conjunction with a calcium phosphate paste (bone substitute material (BSM)), or ORIF alone. This study investigated the ability of BSM to preserve Bohler's angle and to reduce calcaneal height collapse. The results indicated that the use of BSM was able to minimize the reduction in Bohler's angle compared to ORIF alone, while not producing differences in general health, and limb specific function.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
